Bath & Body Works, Inc. (NYSE:BBWI - Get Free Report)'s stock price passed below its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $19.81 and traded as low as $19.19. Bath & Body Works shares last traded at $19.2210, with a volume of 9,043,035 shares traded.
Analyst Ratings Changes
BBWI has been the topic of several recent research reports. BMO Capital Markets initiated coverage on shares of Bath & Body Works in a report on Tuesday, September 8th. They issued a "market perform" rating and a $20.00 price target on the stock. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Bath & Body Works in a research report on Tuesday, October 6th. Robert W. Baird reduced their price target on Bath & Body Works from $25.00 to $23.00 and set a "neutral" rating for the company in a research report on Thursday, August 27th. JPMorgan Chase & Co. lifted their price objective on shares of Bath & Body Works from $22.00 to $24.00 and gave the company a "neutral" rating in a report on Tuesday, August 18th. Finally, Citigroup upgraded Bath & Body Works from a "neutral" rating to a "buy" rating and set a $25.00 price target for the company in a research note on Tuesday, August 18th. Four equities research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, Bath & Body Works has a consensus rating of "Hold" and a consensus target price of $22.53.
Read Our Latest Analysis on BBWI
Bath & Body Works Price Performance
The stock has a market capitalization of $3.88 billion, a PE ratio of 5.01, a price-to-earnings-growth ratio of 1.06 and a beta of 1.31. The stock's 50 day moving average is $19.20 and its two-hundred day moving average is $19.81.
Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings results on Wednesday, August 26th. The company reported $0.62 EPS for the quarter, beating the consensus estimate of $0.24 by $0.38. The company had revenue of $1.51 billion for the quarter, compared to analyst estimates of $1.50 billion. Bath & Body Works had a net margin of 10.83% and a negative return on equity of 53.48%. The firm's revenue was down 2.3% on a year-over-year basis. During the same period in the prior year, the firm posted $0.30 earnings per share. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. On average, equities analysts predict that Bath & Body Works, Inc. will post 2.74 earnings per share for the current year.
Bath & Body Works Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, December 4th. Shareholders of record on Friday, November 20th will be given a dividend of $0.20 per share. The ex-dividend date is Friday, November 20th. This represents a $0.80 annualized dividend and a yield of 4.2%. Bath & Body Works's payout ratio is presently 20.83%.
Institutional Investors Weigh In On Bath & Body Works
Institutional investors have recently modified their holdings of the company. Elevation Wealth Partners LLC grew its stake in Bath & Body Works by 5,278.8% in the 2nd quarter. Elevation Wealth Partners LLC now owns 1,775 shares of the company's stock valued at $41,000 after acquiring an additional 1,742 shares during the last quarter. Parallel Advisors LLC increased its stake in Bath & Body Works by 35.5% in the first quarter. Parallel Advisors LLC now owns 2,570 shares of the company's stock valued at $48,000 after purchasing an additional 673 shares during the last quarter. Meeder Asset Management Inc. acquired a new position in shares of Bath & Body Works during the 2nd quarter valued at about $66,000. Global Retirement Partners LLC acquired a new position in shares of Bath & Body Works in the 2nd quarter valued at $71,000. Finally, United Southern Bank Trust Department purchased a new stake in shares of Bath & Body Works during the 3rd quarter valued at $58,000. Hedge funds and other institutional investors own 95.14% of the company's stock.
Bath & Body Works Company Profile
(
Get Free Report)
Bath & Body Works, Inc. is a specialty retailer focused on personal care and home fragrance products. Its offerings include body lotions, soaps, fragrances, hand sanitizers, candles and other home-fragrance items, sold under the Bath & Body Works and White Barn brands. The company serves customers through its stores and e-commerce platform in the United States and Canada, as well as through international franchise, license and wholesale partners. Bath & Body Works traces its roots to a store launched in 1990.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.